What’s on Our (DR) Radar?
Exploring the real-world impact of artificial intelligence in diabetic retinopathy screening. Diabetes is becoming a global epidemic; the number of people affected worldwide has risen from 108 million in 1980 to an estimated 463 million in 2019, with an estimated 700 million by 2045 (1). Diabetic retinopathy (DR) and its sight-threatening effects are expected to … Czytaj dalejWhat’s on Our (DR) Radar?